![Xiaofang Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Xiaofang Wang
Entité | Type d'entité | Industrie | |
---|---|---|---|
ImStem Biotechnology, Inc.
![]() ImStem Biotechnology, Inc. Medical SpecialtiesHealth Technology ImStem Biotechnology, Inc. operates as a biotechnology company. It focuses on developing cell therapeutic products. Its cell therapeutic products are derived from human pluripotent stem cells for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. The company was founded by Xinghua Victor Pan, Ren-He Xu, Michael Men, and Xiaofang Wang in June 2012 and is headquartered in Farmington, CT.
4
| Private Company | Medical Specialties | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Xiaofang Wang via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Sales & Marketing | |
Tel-Aviv University
![]() Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Swedish Orphan Biovitrum, Inc.
![]() Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Pharmaceuticals: Major | President | |
SANA AB | Biotechnology | Chief Executive Officer | |
Recanati Business School Tel Aviv University | College/University | Masters Business Admin | |
LANDFAR BIO-MEDICINE CO., LTD | Drugstore Chains | Director/Board Member | |
University of South China | College/University | Undergraduate Degree | |
Central South University | College/University | Graduate Degree | |
Bar-Ilan University | College/University | Doctorate Degree | |
University of Tokyo | College/University | Doctorate Degree |
Statistiques
Internationale
Chine | 4 |
Etats-Unis | 3 |
Israël | 3 |
Suède | 2 |
Danemark | 2 |
Sectorielle
Consumer Services | 7 |
Health Technology | 5 |
Retail Trade | 2 |
Opérationnelle
Director/Board Member | 4 |
President | 3 |
Chief Executive Officer | 3 |
Founder | 3 |
Undergraduate Degree | 2 |
Relations les plus connectées
Insiders | |
---|---|
Rami Levin | 7 |
Ren He Xu | 6 |
Xinghua Victor Pan | 1 |
Michael Men | 1 |
- Bourse
- Insiders
- Xiaofang Wang
- Connexions Sociétés